WOWIO is a technology development company with a patented process and a proprietary mobile ad-delivery platform that is designed to disrupt the eBook distribution landscape by exploiting a previously untapped marketplace: ad-supported eBooks. Exclusive ownership of an issued patent that … Continue reading →

MELA Sciences is a medical technology company dedicated to designing and developing innovative software-driven technologies that assist physicians during the clinical evaluation and detection of skin cancer. The company conducted the largest, positive prospective study ever done on the melanoma … Continue reading →

DelMar Pharmaceuticals is focused on the development and commercialization of proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. The company’s lead asset, VAL-083, is currently undergoing clinical trials in the U.S. … Continue reading →

NXT-ID is focused on the growing m-commerce market, launching its innovative MobileBio® suite of biometric solutions that secure consumers’ mobile platforms led by the Wocket™; a next generation smart wallet designed to replace all the cards in your wallet, with … Continue reading →

Cleveland BioLabs is an innovative biopharmaceutical company seeking to develop first-in-class pharmaceuticals designed to address diseases with significant unmet medical need. The company’s programs are focused on the implementation of novel pharmacological approaches to control cell death. Its proprietary drug … Continue reading →

Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. The company’s patented “Veto-Cell” technology addresses one of the most fundamental challenges in human immunology: how to tune immune response so … Continue reading →

Symbid provides a unique legal-financial structure that allows non-accredited investors to invest online in start-ups and growing companies for as little as $27 (EUR20). The company has emerged as a global leader in equity crowdfunding due to its innovative technological … Continue reading →

Milestone Scientific has developed epidural and intra-articular drug delivery systems based on a patented, painless, computer-controlled injection and drug delivery technology originally developed by Milestone Scientific, Inc. Development of both the epidural and intra-articular injection systems is now complete and … Continue reading →

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, Oramed’s Protein Oral Delivery (POD™) technology is based on over 30 years of research by top scientists at … Continue reading →